Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Seaport Global Downgrades Tilly’s to Neutral

Seaport Global Downgrades Tilly’s to Neutral

Seaport Global analyst Mitch Kummetz downgrades Tilly's (NYSE:TLYS) from Buy to Neutral.

byBenzinga Newsdesk

September 2, 2022

1 minute read

Seaport Global analyst Mitch Kummetz downgrades Tilly’s (NYSE:TLYS) from Buy to Neutral.

Truist Securities Initiates Coverage On Whitestone REIT with Hold Rating, Announces Price Target of $10

By Benzinga Newsdesk

August 30, 7:15 AM

Truist Securities analyst Anthony Hau initiates coverage on Whitestone REIT (NYSE:WSR) with a Hold rating and announces Price Target of $10.

WSR

Taiwan Semi’s AI Boom and US Expansion Set to Drive Q1 Earnings Growth

By Anusuya Lahiri

April 16, 7:24 AM

TSM expects 5% rise in Q1 profit, aided by AI demand. It expands in US with $6.6B subsidies. Analysts predict high teens of revenue by 2025.

AAPL

Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection In Cancer Validated By Cas9-Directed Nanopore Sequencing

By Benzinga Newsdesk

April 24, 8:14 AM

Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the results of an implementation study conducted by researchers at University Medical Center Groningen that compared optical genome mapping (OGM) to traditional

BNGO

What’s Up With Pacific Biosciences Stock?

By Ryan Gustafson

December 19, 6:52 PM

Pacific Biosciences of California Inc (NASDAQ: PACB) shares traded higher on Tuesday.

PACB

Seaport Global Downgrades Tilly’s to Neutral

Related Posts

Truist Securities Initiates Coverage On Whitestone REIT with Hold Rating, Announces Price Target of $10

Taiwan Semi’s AI Boom and US Expansion Set to Drive Q1 Earnings Growth

Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection In Cancer Validated By Cas9-Directed Nanopore Sequencing

What’s Up With Pacific Biosciences Stock?